SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Procyon Biopharma Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: thebeach who wrote (346)6/16/2003 9:13:40 AM
From: thebeach  Read Replies (1) of 356
 
Very interesting feature on Hans Mader and Procyon Biopharma in the Journal de Montréal newspaper today ( saturday June 14
).

He gets the spotlight along with Mr. Yves Séguin new Quebec finance minister ( provincial budget ) in the Your Money insert.
Full page detailing a portrait of Hans Mader president of Procyon Biopharma. Anything about his professional career, the
creation of Procyon Biopharma and its move from London to Montreal.

He describes the need for further consolidation in the biotechnology sector and that the old say "small is beautiful" doesn't apply
to the industry. He wishes to do more than the $7M Pharmacor acquisition. The next step would be to continue to get other
business agreements but in the $20M - $30M range to attain a minimal market cap of $100M U.S. He feels it's the only way to
catch the U.S. investors' attention.
As other entrepreneurials from the same biotech industry he has an ambitious dream of becoming the new Biochem Pharma.
Procyon is waiting to get the final results on the PSP94 technology to sign a licence agreement with a pharmaceutical company
before the end of the year.
Mr Mader plans the market launching of PSP94 in 2004. Then Colopath in 2005 and Fibrostat in 2008.

Excellent exposure on Procyon and its leader Hans Mader.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext